American Airlines Cargo Opens Philadelphia Facility

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-07-01-2015
Volume 11
Issue 7

A 25,000-sq-ft cargo facility at Philadelphia International Airport offers different levels of temperature storage.

 

American Airlines Cargo announced on June 25 that it has opened its ExpediteTC° cold storage pharmaceutical facility at Philadelphia International Airport in Philadelphia, PA.

The facility and its specially trained employees are key elements in the effective handling of the sensitive, valuable and potentially life-saving products shipped through the international cold chain. This facility is a continuation of American’s investment in the infrastructure to support the ExpediteTC° time- and temperature-sensitive program.

The 25,000-sq-ft facility includes 6000 sq-ft of space for storage for controlled room-temperature passive shipments at +15 °C to +25 °C .

A 3000-sq-ft refrigerated area holds passive shipments requiring +2 °C to +8 °C conditions; a deep frozen area handles shipments needing that must be kept at -10 °C to -20 °C.

Other features include an active container management area, including charging stations; technology for monitoring products validated to 0.25 °C; a back-up power generation system; and monitoring for 24 hours per day, 7 days per week.

The company offers active and passive cold chain shipping options. ExpediteTC active solution uses temperature-controlled containers that actively regulate temperature levels.

The passive offering is designed for shipper-validated or qualified pre-packaged shipments that require additional sensitivity to temperature control during transport. Cold packs or dry ice used in packaging are aided by temperature-controlled environments along the cold chain, according to company literature.

Source: American Airlines Cargo

 

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content